Experts and support workers have raised concerns that disability benefit payments in the United Kingdom may inadvertently contribute to relapse among individuals with substance abuse problems. Personal Independence Payment (PIP), a non-means-tested disability benefit designed to cover the additional costs of living with a disability, is typically awarded at a rate of up to £194 per week. However, when claimants receive large lump-sum back payments after their claims are approved or successfully appealed, some experts say these windfalls are often spent immediately on drugs and alcohol, increasing the risk of relapse.

Almost 18,000 people currently receive PIP where substance or alcohol abuse is recorded as the primary disabling condition. Many claimants with addiction issues are awarded PIP on the basis of related mental health conditions such as anxiety or depression. Last year, the government reportedly spent around £128 million on PIP for claimants classified as having “substance misuse problems.”

Support professionals from various rehabilitation centres have described instances in which patients relapsed shortly after receiving significant back payments. Sue Gwyn, chief executive of Brynawel Rehabilitation Centre in Pontyclun, northwest of Cardiff, said it was “not infrequent” that back payments would trigger a relapse even among those in recovery, as the sudden financial freedom presents a heightened vulnerability exploited by addiction. Similarly, a staff member at a rehabilitation clinic in Lancashire warned that unrestricted lump sum payments could worsen clients' conditions instead of aiding recovery, noting that none of the funds were typically used to secure housing or support treatment. This staff member also reported that requests to pay benefits in smaller instalments were rejected by local Department for Work and Pensions (DWP) offices, which said the current system does not allow it.

Medical professionals who specialise in addiction have expressed concern that lump sums increase risks for vulnerable patients. Bernadette Hard, a GP from south Wales with two decades of experience in addiction treatment, described a case where a patient anticipating a £15,000 back payment dropped out of treatment and relapsed despite harm reduction efforts, including the prescription of naloxone to counter opioid overdose. Hard advocated for the introduction of “simple checks” and questioned whether providing large sums of money in cash might be exacerbating risks for these individuals.

Former heroin addict Jonathan Hardisty, now a substance abuse support worker, emphasized that the risk of overdose linked to such payments has intensified with the emergence of synthetic opiates. Hardisty recalled receiving thousands of pounds in back payments during his addiction in 2016, which he fully spent on drugs. He also highlighted that it was common advice among peers to appeal rejected claims knowing it could lead to even larger financial awards, which were often quickly used to fund substance abuse rather than addressing related conditions like ADHD, for which he was also claiming.

The challenges are compounded by reductions in public funding for rehabilitation services. A 2021 review by Dame Carol Black found that cuts to the public health budget since 2014 have left addiction treatment largely reliant on a small number of charities. Gwyn noted that the proportion of patients self-funding rehabilitation has risen sharply, with about 35 percent now paying for treatment privately—often individuals without substantial means. She argued that while rehabilitation funding has diminished, benefit payments continue, enabling unrestricted spending on substances.

The Department for Work and Pensions acknowledged that substance use disorders often coexist with other health conditions and stated that PIP, as implemented since 2013, is no longer fit for purpose. The department referred to the recommendations of the Timms review, which are expected to form the basis for future reforms aimed at making the benefit system more effective and safer for vulnerable claimants.